ARTICLE
29 June 2020

Webinar: Supplementary Protection Certificates - Part 1

D
Dehns

Contributor

Founded in 1920, Dehns is one of Europe’s largest full service intellectual property firms, with offices in London, Munich, Oslo, Oxford, Bristol, Brighton, Manchester and Birmingham.

In addition to obtaining patent, trade mark and design protection around the world, our services also extend to IP management consulting and dispute resolution. Dehns attorneys have expertise in a wide range of technologies across the engineering, chemistry and biotechnology sectors.

Our clients include private inventors, universities and research institutions, start-ups and SMEs as well as large multinational corporations. We are firmly focussed on delivering clear advice and valuable results at a competitive cost.

Dehns’ straightforward, business-oriented approach combined with technical excellence has made us leaders in our field and we are proud of our top tier rankings.

Hosted by Chris Goddard on 25 June 2020, this webinar is the first in a two part series covering Supplementary Protection Certificates.
United Kingdom Intellectual Property

Hosted by Chris Goddard on 25 June 2020, this webinar is the first in a two part series covering Supplementary Protection Certificates.

A Supplementary Protection Certificate (SPC) is a form of intellectual property that can extend the protection of patented active ingredients present in pharmaceutical or plant protection products by up to five years. In this webinar, we cover an introduction to SPCs, along with the basics of obtaining an SPC, its term and scope of protection.

Chris is a qualified European and UK patent attorney and a Partner at Dehns. He graduated from the University of Cambridge in with a degree in Natural Sciences (Chemistry) and was awarded a PhD, also by the University of Cambridge. He works for a variety of clients from sole-inventors and small biotech companies to multinational corporations. He works with inventions from a broad range of chemical technologies including organic chemistry, pharmaceuticals, drug delivery formulations, diagnostic assays, medical devices, solar cells and renewable energy. He provides patent drafting, filing, international prosecution and strategic IP portfolio advice and has experience in oppositions and appeals before the EPO.

Click here to hear about our upcoming webinars.

Originally published 26 June, 2020

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More